COMPANY
AnaBios Corporation
NIH awards 7
- NIH award 1R44NS119036-01 FY2021: $1,734,409 awarded for that fiscal year; activity R44 (SBIR); PI GHETTI, ANDREA; recipient as written: ANABIOS CORPORATION, SAN DIEGO, CA. Development of a novel analgesic for mixed source ↗
- NIH award 1R43DA052947-01 FY2020: $320,054 awarded for that fiscal year; activity R43 (SBIR); PI GHETTI, ANDREA; recipient as written: ANABIOS CORPORATION, SAN DIEGO, CA. Development of a novel translational pain-dru source ↗
- NIH award 1R44TR003162-01 FY2020: $1,132,289 awarded for that fiscal year; activity R44 (SBIR); PI ABI GERGES, NAJAH; recipient as written: ANABIOS CORPORATION, SAN DIEGO, CA. Development of an Integrated Platform fo source ↗
- NIH award 1U01FD006879-01 FY2019: $247,461 awarded for that fiscal year; activity U01 (OTHER_NIH); PI ABI GERGES, NAJAH; recipient as written: ANABIOS CORPORATION, SAN DIEGO, CA. DEVELOPMENT AND QUALIFICATION OF A BI source ↗
- NIH award 5R44TR001133-03 FY2017: $549,693 awarded for that fiscal year; activity R44 (SBIR); PI GHETTI, ANDREA; recipient as written: ANABIOS CORPORATION, SAN DIEGO, CA. Validation and qualification of an ex vivo hu source ↗
- NIH award 2R44TR001133-02A1 FY2016: $945,014 awarded for that fiscal year; activity R44 (SBIR); PI GHETTI, ANDREA; recipient as written: ANABIOS CORPORATION, SAN DIEGO, CA. Validation and qualification of an ex vivo source ↗
- NIH award 1R43TR001133-01 FY2014: $200,651 awarded for that fiscal year; activity R43 (SBIR); PI GHETTI, ANDREA; recipient as written: ANABIOS CORPORATION, SAN DIEGO, CA. Validation and qualification of an ex vivo hu source ↗